SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Press Releases

2016 :: 2015  ::  2014 :: 2013 ::  2012  ::  2011 :: 2010

University of Washington Leads All SynCardia Certified Centers
with 10 Implants of the Total Artificial Heart in 2012

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that University of Washington (UW) Medical Center in Seattle has performed 10 implants of the SynCardia temporary Total Artificial Heart so far in 2012, the most of any SynCardia Certified Center this year. It also marks a new record for number of implants performed by a hospital during its first year as a SynCardia Certified Center...

Continue Reading

SynCardia Wins Copper Cactus Award for Innovation and Two Best in Biz Awards

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that it has been honored with three awards in November...

Continue Reading

Hiker without Human Heart Receives Heart Transplant 607 Miles Later

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that avid hiker Chris Marshall, who received the SynCardia temporary Total Artificial Heart in February, has been successfully bridged to a heart transplant at University of Washington (UW) Medical Center in Seattle...

Continue Reading

Mount Sinai Medical Center 1st in Tri-State Area to Discharge Patient without Human Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that The Mount Sinai Medical Center in New York City, has become the first hospital in the tri-state area to discharge a patient implanted with the SynCardia temporary Total Artificial Heart. On Oct. 25, Daquain Jenkins left the hospital to wait for a matching donor heart at home using the Freedom® portable driver to power his Total Artificial Heart...

Continue Reading

1st Total Artificial Heart Patient Discharged from Ege University in Turkey

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that for the first time in Izmir, Turkey, a patient implanted with the SynCardia temporary Total Artificial Heart has been discharged from the hospital. On Sept. 26, 57-year-old Nurullah Balik was discharged from Ege University Hospital to wait for a matching donor heart at home using the Freedom® portable driver to power his Total Artificial Heart...

Continue Reading

SynCardia Co-Founder Dr. Marvin Slepian Helps Develop
Biodegradable Electronics that Vanish Inside the Body

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Marvin J. Slepian, MD, the company's co-founder, chief scientific officer and chairman of its Science Advisory Board, has helped develop a new class of small, high-performance electronics that are biodegradable and capable of dissolving completely in water or bodily fluids. The applications which appear most promising for this transient technology are medical implants, consumer electronics and environmental monitors...

Continue Reading

San Raffaele Hospital in Italy Discharges First SynCardia Total Artificial Heart Patient Home

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that San Raffaele Hospital in Milan, Italy, has discharged its first patient to receive the SynCardia temporary Total Artificial Heart. On Sept. 7, 55-year-old Marco Fumagalli left the hospital to wait for a matching donor heart at home using the Freedom® portable driver to power his Total Artificial Heart...

Continue Reading

Slovenia's First Total Artificial Heart Patient Receives Heart Transplant

SynCardia Systems, Inc., manufacturer of  the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that University Medical Center (UMC) Ljubljana has transplanted Slovenia's first patient to receive the SynCardia temporary Total Artificial Heart. The patient, 61-year-old Nikola Gašpic, received a matching donor heart on July 1, after 256 days of life with the Total Artificial Heart...

Continue Reading

1st Patient in Illinois Discharged Home with the SynCardia Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Advocate Christ Medical Center in Oak Lawn, Illinois, has discharged its first patient to receive the SynCardia temporary Total Artificial Heart. Leroy Haynes, 64, left the hospital using the Freedom® portable driver on Sept. 13, to resume life at home with his wife Pat while he waits for a matching donor heart...

Continue Reading

University of Kentucky Medical Center Transplants State's 1st SynCardia Total Artificial Heart Patient

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that University of Kentucky (UK) Medical Center has successfully transplanted its first patient to receive the SynCardia temporary Total Artificial Heart. Zack Poe, 21, received his matching donor heart in July after five months of life with the Total Artificial Heart...

Continue Reading

SynCardia Total Artificial Heart Patient Featured in U.S. News & World Report's "Best Hospitals" Issue

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Michelle Johnson, a 39-year-old mother of three who received the SynCardia temporary Total Artificial Heart in January, is featured in the cover story of U.S. News & World Report's "Best Hospitals" issue. The 2012-2013 guidebook to the nation's top hospitals hits newsstands on Aug. 28...

Continue Reading

Man Without Human Heart Hikes More Than 400 Miles

Hiking up to six miles every day isn't for the faint of heart. Luckily for Chris Marshall, he doesn't have one. Marshall, the first SynCardia temporary Total Artificial Heart patient in the Pacific Northwest to leave the hospital using the Freedom® portable driver, has logged more than 400 miles of hiking since being discharged from University of Washington Medical Center on March 29...

Continue Reading

50% of U.S. News & World Report’s “Best Hospitals” for Cardiology & Heart Surgery
Making the SynCardia Total Artificial Heart Part of Their Toolbox

SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that among the top 50 centers honored in U.S. News & World Report’s “Best Hospitals” list for cardiology and heart surgery, 15 are certified to implant the SynCardia temporary Total Artificial Heart, five are currently completing certification and an additional five are starting certification...

Continue Reading

3 Pediatric Centers that Offer SynCardia Total Artificial Heart
Named in Top 10 for "Best Children's Hospitals"

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that U.S. News & World Report has named three pediatric centers that offer the SynCardia temporary Total Artificial Heart among the nation's Top 10 "Best Children's Hospitals" for Cardiology and Heart Surgery in its annual list. The Children's Hospital of Philadelphia (CHOP) was ranked #2, Texas Children's Hospital was ranked #3 and Cincinnati Children's Hospital Medical Center was ranked #9...

Continue Reading

SynCardia Wins 2012 Medical Design Excellence Award

SynCardia Systems, Inc., the privately-held manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the company's Freedom® portable driver, the world's first wearable power supply for the SynCardia temporary Total Artificial Heart, was selected as the Bronze Winner in the Critical Care and Emergency Medicine category of the 2012 Medical Design Excellence Awards (MDEA) on May 23 in Philadelphia...

Continue Reading

Cedars-Sinai Implants 1st SynCardia Total Artificial Heart
to Bridge Mother of Three to Second Heart Transplant

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, said today that Cedars-Sinai Medical Center in Los Angeles has discharged its first patient to be implanted with the SynCardia temporary Total Artificial Heart. Michelle Johnson, 39, left the hospital to wait for a matching donor heart at home using the Freedom® portable driver to power her Total Artificial Heart...

Continue Reading

8 SynCardia Certified Centers & Surgeons Honored for Use of Total Artificial Heart at ISHLT

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, honored eight SynCardia Certified Centers and surgeons for their use of the SynCardia temporary Total Artificial Heart and the Freedom® portable driver during the annual meeting of the International Society for Heart & Lung Transplantation (ISHLT) held April 18-21 in Prague, Czech Republic...

Continue Reading

Retired Pro Hockey Player 1st to Receive Total Artificial Heart in Upstate New York

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that retired professional hockey player and two-time Olympian, Gaetano "Gates" Orlando, has become the first person in upstate New York to receive the SynCardia temporary Total Artificial Heart. The 49-year-old, who played for the Buffalo Sabres and Rochester Americans, as well as the Italian national team in the 1994 and 1998 Olympics, received the Total Artificial Heart on April 4, at University of Rochester Medical Center (URMC)...

Continue Reading

SynCardia's Total Artificial Heart Receives HUD Designation for Destination Therapy from FDA

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the U.S. Food and Drug Administration (FDA) has approved a Humanitarian Use Device (HUD) designation for the SynCardia temporary Total Artificial Heart to be used for destination therapy in addition to its current PMA approval as a bridge to transplant...

Continue Reading

Record Number of ISHLT Abstracts Discuss SynCardia's Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that this year's annual meeting of the International Society for Heart & Lung Transplantation (ISHLT) being held April 18-21 in Prague, Czech Republic, features a record number of abstracts discussing the SynCardia temporary Total Artificial Heart...

Continue Reading

University of Washington Medical Center 1st in Pacific Northwest
to Discharge a Patient Without a Human Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that on March 21, University of Washington (UW) Medical Center became the first hospital in the Pacific Northwest to discharge a patient without a human heart. Christopher Marshall, 51, is now waiting for a matching donor heart in Seattle using the Freedom® portable driver to power his SynCardia temporary Total Artificial Heart...

Continue Reading

University of Kentucky Medical Center Discharges State's 1st SynCardia Total Artificial Heart Patient

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that on March 5, University of Kentucky Medical Center (UK) in Lexington discharged its first patient to be implanted with the SynCardia temporary Total Artificial Heart. Zack Poe, 20, is the first patient in the state to leave the hospital to wait for a matching donor heart at home using the Freedom® portable driver to power his Total Artificial Heart...

Continue Reading

SynCardia Names New Chief Operating Officer

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Douglas Nutter has joined the company as its new Chief Operating Officer (COO). Mr. Nutter will oversee manufacturing, quality and engineering at SynCardia...

Continue Reading

1,000th Implant of the World's Only Approved Total Artificial Heart Performed

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that the 1,000th implant of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart was performed on Feb. 10 at The University of Arizona Medical Center in Tucson, AZ. Since then, an additional four implants of the Total Artificial Heart have been performed at SynCardia Certified Centers in Germany, France and the United States...

Continue Reading

Total Artificial Heart Patient Receives Donor Heart 15 Years after Decision to Donate Wife's Organs

Gregory Welsh, 47, is a compelling example of the life-changing importance of organ donation. Following a car accident in 1996, he made the decision to donate his wife's organs in hopes of helping others. Fifteen years later, Mr. Welsh's gift came full circle when he received a donor heart transplant after 120 days of life with the SynCardia temporary Total Artificial Heart...

Continue Reading

Slovenia's 1st Total Artificial Heart Patient Discharged
from UMC Ljubljana Using the Freedom® Portable Driver

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that on Dec. 29, 2011, University Medical Center (UMC) Ljubljana discharged Slovenia's first Total Artificial Heart patient, 61-year-old Nikola Gašpic, to wait for a matching donor heart at home using the Freedom® portable driver...

Continue Reading

Search offcanvas